BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35905195)

  • 1. Colorectal cancer chemoprevention: is aspirin still in the game?
    Grancher A; Michel P; Di Fiore F; Sefrioui D
    Cancer Biol Ther; 2022 Dec; 23(1):446-461. PubMed ID: 35905195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer: Past, present, and future.
    Umezawa S; Higurashi T; Komiya Y; Arimoto J; Horita N; Kaneko T; Iwasaki M; Nakagama H; Nakajima A
    Cancer Sci; 2019 Oct; 110(10):3018-3026. PubMed ID: 31361372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aspirin and colorectal cancer].
    Grancher A; Michel P; Di Fiore F; Sefrioui D
    Bull Cancer; 2018 Feb; 105(2):171-180. PubMed ID: 29153543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
    Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies.
    Zaman FY; Orchard SG; Haydon A; Zalcberg JR
    Br J Cancer; 2022 Nov; 127(10):1735-1743. PubMed ID: 35764787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for the prevention of colorectal cancer.
    Garcia-Albeniz X; Chan AT
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):461-72. PubMed ID: 22122763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
    Dubé C; Rostom A; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
    Ann Intern Med; 2007 Mar; 146(5):365-75. PubMed ID: 17339622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Select Patients for Colorectal Cancer Prevention with Aspirin?
    Kraus S; Sion D; Arber N
    Curr Pharm Des; 2015; 21(35):5127-34. PubMed ID: 26369678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using aspirin to prevent and treat cancer.
    Lichtenberger LM
    Inflammopharmacology; 2024 Feb; 32(1):903-908. PubMed ID: 38064111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspirin for Chemoprevention of Colorectal Adenoma and Cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 2021 Dec; 48(12):1425-1428. PubMed ID: 34911904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
    Benamouzig R; Uzzan B; Little J; Chaussade S
    Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
    BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
    Podhorec J; Hrstka R; Bílek O; Tuček Š; Navrátil J; Michalová E; Vojtěšek B
    Klin Onkol; 2018; 31(Suppl 2):77-81. PubMed ID: 31023028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
    Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.